ARCHIVES

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

ODAC Oks Melphalan Injection WR-2721 Needs More Data

February 7, 1992

UPCI Opens New Facility; Gomella Wins NCI Award.

July 4, 2003

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

January 9, 1998

NCCN Also to Warn Doctors. Amgen’s Pledges to Disclose Future Results.

February 23, 2007

ECG Disputes Accrual Figures Cited By DeVita, Says Numbers Are Up 17% This Year And Still Rising

July 8, 1988

In Brief: Panel to Meet Jan. 30 In Los Angeles; Fate Of Proposed Urologic Group Depends On Budget

January 10, 1986